Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| cancer long prostate survival term |
|
The Journal of Urology : Lymph Node Positive Prostate Cancer: Long Lymph Node Positive Prostate Cancer: Long-Term Survival Data After Radical Prostatectomy. ULRIKE ZWERGELa, JAN LEHMANNa, BERND WULLICHa, ULRICH SCHREIERa, IngentaConnect Long-term Survival of Prostate Cancer in Long-term Survival of Prostate Cancer in Southeastern Netherlands. Authors: Post P. N.1; Hendrikx A. J. M.; Hansen B. E.; van der Heijden L. H.; Radiation therapy combo cures prostate cancer long-term Radiation therapy combo cures prostate cancer long-term "15-Year Biochemical Relapse Free Survival in Clinical Stage T1-T3 Prostate Cancer Following Long-term survival probability in men with clinically localized OBJECTIVES: To report the long-term survival probability in more than 3000 men with localized prostate cancer treated either conservatively or by definitive Prostate Cancer: More Long-term Research Needed on Cryosurgery as Prostate Cancer: More Long-term Research Needed on Cryosurgery as a because they would help determine the long-term survival benefits and make possible Prostatectomy Offers Highest Long-Term Survival Rate for Localized The prostate cancer specific long-term survival rate (meaning that prostate cancer had not killed then men) were 92 percent with prostatectomy, Long-Term Survival Probability In Men With Clinically Localized Long-Term Survival Probability In Men With Clinically Localized Prostate Cancer Treated Either Conservatively Or With Definitive Treatment Prostate Cancer, The Cancer Information Network Long-Term Survival of Clinically Localized Prostate Cancer - Selective professional reading for patients and caregivers. A large population-based study from Period Analysis of Prostate Cancer Survival -- Wilding and Long-Term Survival Rates of Patients With Prostate Cancer in the Prostate-Specific Antigen Screening Era: Population-Based Estimates for the Year 2000 by Long-term Hormone Use Helps Prostate Cancer Patients Live Longer The five-year overall survival rate was 87.5 percent for the long-term group and 75 percent in the short-term group. The chance of dying of prostate cancer |
| cancer long prostate survival term |
|
enlarged prostate cause color prostate sonograms aneros helix eupho prostate stimulators cancer denver prostate radiation treatment |